|
KR101483215B1
(ko)
*
|
2010-01-29 |
2015-01-16 |
한미약품 주식회사 |
단백질 키나아제 저해활성을 갖는 비시클릭 헤테로아릴 유도체
|
|
KR20190077610A
(ko)
*
|
2010-07-13 |
2019-07-03 |
에프. 호프만-라 로슈 아게 |
Irak4 조절제로서 피라졸로[1,5a]피리미딘 및 티에노[3,2b]피리미딘 유도체
|
|
EP2663312B1
(en)
|
2011-01-10 |
2017-10-11 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
WO2012129258A1
(en)
|
2011-03-22 |
2012-09-27 |
Merck Sharp & Dohme Corp. |
Amidopyrazole inhibitors of interleukin receptor-associated kinases
|
|
EP2723746A1
(en)
|
2011-06-22 |
2014-04-30 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
|
AU2012363558C1
(en)
*
|
2011-12-30 |
2019-08-29 |
Hanmi Pharm Co., Ltd. |
Thieno[3,2-d]pyrimidine derivatives having inhibitory activity for protein kinases
|
|
JP6109193B2
(ja)
|
2012-01-10 |
2017-04-05 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
チエノピリミジン化合物
|
|
AU2013207972B2
(en)
|
2012-01-10 |
2017-06-15 |
Nimbus Iris, Inc. |
IRAK inhibitors and uses thereof
|
|
WO2014003483A1
(en)
*
|
2012-06-29 |
2014-01-03 |
Hanmi Pharm. Co., Ltd. |
Fused pyrimidine derivatives having inhibitory activity on fms kinases
|
|
HUE029559T2
(en)
*
|
2012-07-10 |
2017-03-28 |
Ares Trading Sa |
Pyrimidine-pyrazolyl derivatives
|
|
US9085586B2
(en)
|
2012-07-11 |
2015-07-21 |
Nimbus Iris, Inc. |
IRAK inhibitors and uses thereof
|
|
US9067948B2
(en)
|
2012-07-11 |
2015-06-30 |
Nimbus Iris, Inc. |
IRAK inhibitors and uses thereof
|
|
WO2014011911A2
(en)
*
|
2012-07-11 |
2014-01-16 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
PT2941432T
(pt)
|
2012-12-07 |
2018-06-01 |
Vertex Pharma |
2-amino-6-fluoro-n-(5-fluoro-4-(4-(4-(oxetan-3- il)piperazina-1-carbonil)piperidin-1-il)piridin-3- il)pirazolo[1,5alfa]pirimidina-3-carboxamida como inibidor da quinase atr
|
|
EP2943202A4
(en)
|
2013-01-10 |
2016-08-24 |
Nimbus Iris Inc |
IRAQ INHIBITORS AND USES THEREOF
|
|
US9278950B2
(en)
|
2013-01-14 |
2016-03-08 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
|
EA035929B1
(ru)
|
2013-01-15 |
2020-09-02 |
Инсайт Холдингс Корпорейшн |
ТИАЗОЛКАРБОКСАМИДЫ И ПИРИДИНКАРБОКСАМИДЫ, ИСПОЛЬЗУЕМЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Pim-КИНАЗЫ
|
|
US8778365B1
(en)
|
2013-01-31 |
2014-07-15 |
Merz Pharmaceuticals, Llc |
Topical compositions and methods for making and using same
|
|
JP2016512239A
(ja)
|
2013-03-15 |
2016-04-25 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
Ａｔｒキナーゼの阻害剤として有用な化合物
|
|
US9663519B2
(en)
|
2013-03-15 |
2017-05-30 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
|
EP2970288A1
(en)
*
|
2013-03-15 |
2016-01-20 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
GB201311891D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compound
|
|
GB201311888D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
EP3019171B1
(en)
*
|
2013-07-11 |
2018-09-05 |
Merck Sharp & Dohme Corp. |
Substituted amidopyrazole inhibitors of interleukin receptor-associated kinases (irak-4)
|
|
MX2016002367A
(es)
*
|
2013-08-23 |
2016-10-28 |
Incyte Corp |
Compuestos de carboxamida de furo y tienopiridina utiles como inhibidores de cinasas pim.
|
|
WO2015048281A1
(en)
|
2013-09-27 |
2015-04-02 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
PT3077397T
(pt)
|
2013-12-06 |
2020-01-22 |
Vertex Pharma |
Composto de 2-amino-6-fluoro-n-[5-fluoro-piridin-3-il]pirazolo[1,5-a]pirimidin-3-carboxamida útil como inibidor da atr quinase, a sua preparação, diferentes formas sólidas e derivados radiomarcados do mesmo
|
|
JP6878004B2
(ja)
|
2013-12-13 |
2021-05-26 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
リンパ形質細胞性リンパ腫を処置する方法
|
|
WO2015089479A1
(en)
|
2013-12-13 |
2015-06-18 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
|
TWI667233B
(zh)
|
2013-12-19 |
2019-08-01 |
德商拜耳製藥公司 |
新穎吲唑羧醯胺，其製備方法、含彼等之醫藥製劑及其製造醫藥之用途
|
|
JP2017505337A
(ja)
|
2014-01-10 |
2017-02-16 |
アウリジーン ディスカバリー テクノロジーズ リミテッド |
Ｉｒａｋ４阻害剤としてのインダゾール化合物
|
|
KR102392684B1
(ko)
|
2014-01-13 |
2022-04-29 |
오리진 디스커버리 테크놀로지스 리미티드 |
Irak4 억제제로서의 바이시클릭 헤테로시클릴 유도체
|
|
CN106459039A
(zh)
*
|
2014-05-23 |
2017-02-22 |
豪夫迈·罗氏有限公司 |
为jak抑制剂的5‑氯‑2‑二氟甲氧基苯基吡唑并嘧啶化合物
|
|
CN107074863B
(zh)
|
2014-06-05 |
2019-12-03 |
沃泰克斯药物股份有限公司 |
Atr激酶抑制剂的制备方法及其不同的固体形式
|
|
MX2016016115A
(es)
|
2014-06-17 |
2017-03-08 |
Vertex Pharma |
Metodo para tratar cancer usando una combinacion de inhibidores de chk1 y relacionado con atm y rad3 (atr).
|
|
US9580418B2
(en)
|
2014-07-14 |
2017-02-28 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
|
US9822124B2
(en)
|
2014-07-14 |
2017-11-21 |
Incyte Corporation |
Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors
|
|
EP3715346B1
(en)
|
2014-10-22 |
2024-01-03 |
Dana-Farber Cancer Institute, Inc. |
Thiazolyl-containing compounds for treating proliferative diseases
|
|
US20180185368A1
(en)
|
2014-11-06 |
2018-07-05 |
Lysosomal Therapeutics Inc. |
Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
|
|
KR102662215B1
(ko)
|
2014-11-06 |
2024-05-02 |
비알 - 알&디 인베스트먼츠, 에스.에이. |
치환된 피라졸로(1,5-a)피리미딘 및 의학적 장애의 치료에서의 그의 용도
|
|
US20170333435A1
(en)
|
2014-11-06 |
2017-11-23 |
Lysosomal Therapeutics Inc. |
Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders
|
|
KR102683518B1
(ko)
*
|
2014-11-20 |
2024-07-10 |
메르크 파텐트 게엠베하 |
Irak 억제제로서 헤테로아릴 화합물 및 이들의 용도
|
|
EP3268004B1
(en)
*
|
2015-03-12 |
2019-12-18 |
Merck Sharp & Dohme Corp. |
Pyrrolopyridazine inhibitors of irak4 activity
|
|
WO2016144848A1
(en)
*
|
2015-03-12 |
2016-09-15 |
Merck Sharp & Dohme Corp. |
Pyrrolotriazine inhibitors of irak4 activity
|
|
EP3268367B8
(en)
|
2015-03-12 |
2022-11-16 |
Merck Sharp & Dohme LLC |
Carboxamide inhibitors of irak4 activity
|
|
US10040802B2
(en)
|
2015-03-12 |
2018-08-07 |
Merck Sharp & Dohme Corp. |
Thienopyrazine inhibitors of IRAK4 activity
|
|
WO2016144846A1
(en)
*
|
2015-03-12 |
2016-09-15 |
Merck Sharp & Dohme Corp. |
Pyrazolopyrimidine inhibitors of irak4 activity
|
|
US9540347B2
(en)
|
2015-05-29 |
2017-01-10 |
Incyte Corporation |
Pyridineamine compounds useful as Pim kinase inhibitors
|
|
WO2017004134A1
(en)
*
|
2015-06-29 |
2017-01-05 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
EA201890307A1
(ru)
*
|
2015-07-15 |
2018-10-31 |
Ориджин Дискавери Текнолоджиз Лимитед |
Индазольные и азаиндазольные соединения как ингибиторы irak-4
|
|
TWI734699B
(zh)
|
2015-09-09 |
2021-08-01 |
美商英塞特公司 |
Ｐｉｍ激酶抑制劑之鹽
|
|
BR112018005331A2
(pt)
|
2015-09-17 |
2018-10-09 |
Hope City |
inibidores de pcna
|
|
CN105237414B
(zh)
*
|
2015-09-30 |
2017-03-22 |
浙江永宁药业股份有限公司 |
ivacaftor中间体及其制备方法和用途
|
|
AU2016331955B2
(en)
|
2015-09-30 |
2022-07-21 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
|
|
TW201718546A
(zh)
|
2015-10-02 |
2017-06-01 |
英塞特公司 |
適用作pim激酶抑制劑之雜環化合物
|
|
CN108473498B
(zh)
*
|
2015-12-22 |
2021-11-02 |
豪夫迈·罗氏有限公司 |
作为IRAK4调节剂的吡唑并[1,5a]嘧啶衍生物
|
|
MX2018012207A
(es)
|
2016-04-06 |
2019-03-28 |
Lysosomal Therapeutics Inc |
Compuestos de pirrol[1,2-a]pirimidinil carboxamida y su uso en el tratamiento de trastornos médicos.
|
|
MX2018012208A
(es)
|
2016-04-06 |
2019-03-28 |
Lysosomal Therapeutics Inc |
Compuestos a base de imidazo [1,5-a] pirimidinil carboxamida y su uso en el tratamiento de trastornos médicos.
|
|
MX2018012211A
(es)
|
2016-04-06 |
2019-03-28 |
Lysosomal Therapeutics Inc |
Compuestos de pirazol[1,5-a]pirimidinil carboxamida y su uso en el tratamiento de trastornos médicos.
|
|
EP3452045A1
(en)
*
|
2016-05-04 |
2019-03-13 |
Lysosomal Therapeutics Inc. |
Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds
|
|
WO2017192931A1
(en)
|
2016-05-05 |
2017-11-09 |
Lysosomal Therapeutics Inc. |
SUBSTITUTED IMDAZO[1,2-α]PYRIDINES, SUBSTITUTED IMIDAZO[1,2-α]PYRAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
|
|
SG11201809693SA
(en)
|
2016-05-05 |
2018-11-29 |
Lysosomal Therapeutics Inc |
SUBSTITUTED IMIDAZO[1,2-b]PYRIDAZINES, SUBSTITUTED IMIDAZO[1,5-b]PYRIDAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
|
|
CN106222183B
(zh)
*
|
2016-07-25 |
2019-11-08 |
南通大学 |
靶向人irak1基因的小干扰rna及其应用
|
|
JP7059268B2
(ja)
*
|
2016-11-02 |
2022-04-25 |
エフ．ホフマン－ラ ロシュ アーゲー |
ＩＲＡＫ４モデュレーターとしてのピラゾロ［１，５ａ］ピリミジン誘導体
|
|
TW201837027A
(zh)
|
2017-02-01 |
2018-10-16 |
以色列商以色列耶路撒冷希伯來大學伊索研究發展有限公司 |
吡唑衍生物及其用途
|
|
JOP20180011A1
(ar)
|
2017-02-16 |
2019-01-30 |
Gilead Sciences Inc |
مشتقات بيرولو [1، 2-b]بيريدازين
|
|
IL293783B2
(en)
|
2017-03-31 |
2024-01-01 |
Aurigene Oncology Ltd |
Compounds and preparations for the treatment of hematological disorders
|
|
CN106946890A
(zh)
*
|
2017-04-26 |
2017-07-14 |
中国药科大学 |
吡啶类irak4抑制剂、其制备方法及应用
|
|
BR112019024322A2
(pt)
|
2017-05-22 |
2020-06-16 |
F. Hoffmann-La Roche Ag |
Compostos e composições terapêuticos e métodos de uso dos mesmos
|
|
JP2020524691A
(ja)
*
|
2017-06-21 |
2020-08-20 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
ＩＲＡＫ４調節因子としてのピラゾロ［１，５ａ］ピリミジン誘導体
|
|
CN110785418A
(zh)
*
|
2017-06-21 |
2020-02-11 |
豪夫迈·罗氏有限公司 |
作为irak4调节剂的异二氢吲哚酮衍生物
|
|
JP2020524692A
(ja)
|
2017-06-21 |
2020-08-20 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
Ｉｒａｋ４調節因子としてのベンゾフラン
|
|
WO2019001460A1
(zh)
*
|
2017-06-27 |
2019-01-03 |
南京明德新药研发股份有限公司 |
作为 irak4 抑制剂的稠环化合物
|
|
JP7114394B2
(ja)
*
|
2017-08-18 |
2022-08-08 |
住友化学株式会社 |
化合物、レジスト組成物及びレジストパターンの製造方法
|
|
US11358948B2
(en)
|
2017-09-22 |
2022-06-14 |
Kymera Therapeutics, Inc. |
CRBN ligands and uses thereof
|
|
IL295603B2
(en)
|
2017-09-22 |
2024-03-01 |
Kymera Therapeutics Inc |
Protein compounds and their uses
|
|
PL3704108T3
(pl)
|
2017-10-31 |
2024-07-22 |
Curis, Inc. |
Inhibitor irak4 w połączeniu z inhibitorem bcl-2 do stosowania w leczeniu nowotworu złośliwego
|
|
EP3710443A1
(en)
|
2017-11-17 |
2020-09-23 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of interleukin-1 receptor-associated kinase 4 polypeptides
|
|
CN111542529B
(zh)
|
2017-11-30 |
2023-06-30 |
韩美药品株式会社 |
对蛋白激酶具有抑制活性的噻吩并[3,2-d]嘧啶化合物
|
|
WO2019111218A1
(en)
|
2017-12-08 |
2019-06-13 |
Cadila Healthcare Limited |
Novel heterocyclic compounds as irak4 inhibitors
|
|
US10596161B2
(en)
|
2017-12-08 |
2020-03-24 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
|
AU2018396142A1
(en)
|
2017-12-26 |
2020-07-16 |
Kymera Therapeutics, Inc. |
IRAK degraders and uses thereof
|
|
EP3737675A4
(en)
|
2018-01-12 |
2022-01-05 |
Kymera Therapeutics, Inc. |
CRBN LIGANDS AND THEIR USES
|
|
EP3737666A4
(en)
|
2018-01-12 |
2022-01-05 |
Kymera Therapeutics, Inc. |
PROTEIN DEGRADANTS AND USES THEREOF
|
|
KR20200140302A
(ko)
|
2018-04-05 |
2020-12-15 |
메르크 파텐트 게엠베하 |
타입 ii irak 억제제로서 헤테로아릴 화합물 및 이의 용도
|
|
WO2020010177A1
(en)
|
2018-07-06 |
2020-01-09 |
Kymera Therapeutics, Inc. |
Tricyclic crbn ligands and uses thereof
|
|
TWI842978B
(zh)
|
2018-07-13 |
2024-05-21 |
美商基利科學股份有限公司 |
衍生物
|
|
CN110862375B
(zh)
*
|
2018-08-27 |
2022-10-25 |
深圳铂立健医药有限公司 |
吡唑化合物及其药物组合物和应用
|
|
EP3873911A4
(en)
|
2018-10-30 |
2022-06-22 |
Kronos Bio, Inc. |
COMPOUNDS, COMPOSITIONS AND METHODS FOR MODULATING CDK9 ACTIVITY
|
|
CA3119773A1
(en)
|
2018-11-30 |
2020-06-04 |
Kymera Therapeutics, Inc. |
Irak degraders and uses thereof
|
|
MX2021015498A
(es)
*
|
2019-06-27 |
2022-04-20 |
Biogen Ma Inc |
Derivados de imidazo[1,2-a]piridinilo y su uso en el tratamiento de enfermedades.
|
|
CN114466844A
(zh)
|
2019-10-02 |
2022-05-10 |
康佳诺医疗科技发展有限公司 |
N-(1h-咪唑-2-基)苯甲酰胺化合物及包含其作为活性成分的药物组合物
|
|
JP2023509366A
(ja)
|
2019-12-17 |
2023-03-08 |
カイメラ セラピューティクス， インコーポレイテッド |
Ｉｒａｋ分解剤およびそれらの使用
|
|
WO2021127283A2
(en)
|
2019-12-17 |
2021-06-24 |
Kymera Therapeutics, Inc. |
Irak degraders and uses thereof
|
|
AU2021248720A1
(en)
|
2020-04-04 |
2022-11-03 |
Pfizer Inc. |
Methods of treating coronavirus disease 2019
|
|
TW202210483A
(zh)
|
2020-06-03 |
2022-03-16 |
美商凱麥拉醫療公司 |
Irak降解劑之結晶型
|
|
WO2022070289A1
(ja)
*
|
2020-09-30 |
2022-04-07 |
旭化成ファーマ株式会社 |
ピリミジン含有含窒素二環化合物
|
|
US11866405B2
(en)
|
2020-12-10 |
2024-01-09 |
Astrazeneca Ab |
Substituted indazoles as IRAK4 inhibitors
|
|
IL314437A
(en)
|
2022-01-31 |
2024-09-01 |
Kymera Therapeutics Inc |
IRAK joints and their uses
|